Beclomethasone Dipropionate Aerosol, Metered
NDC Package 13107-230-54

11-digit billing NDC: 13107023054

Package Information

Beclomethasone Dipropionate aerosols is beclomethasone is used to prevent and treat seasonal and year-round allergy symptoms (such as stuffy/runny nose, itchy eyes/nose/throat, sneezing). This formulation utilizes a aerosol, metered delivery system. Marketed by Aurolife Pharma Llc, this product is identified by NDC 13107-230 and is authorized under FDA application ANDA214418.

Identification & Billing

NDC Package Code
13107-230-54
Package Description
1 CANISTER in 1 CARTON / 120 AEROSOL, METERED in 1 CANISTER
Product Code
11-Digit Billing Format
13107023054

Clinical Specifications

Proprietary Name
Beclomethasone Dipropionate
Non-Proprietary Name
Beclomethasone Dipropionate
Substance Name
Beclomethasone Dipropionate
Dosage Form
Aerosol, Metered - A pressurized dosage form consisting of metered dose valves which allow for the delivery of a uniform quantity of spray upon each activation.
Administration Route
Respiratory (inhalation) - Administration within the respiratory tract by inhaling orally or nasally for local or systemic effect.
Usage Information
Beclomethasone is used to prevent and treat seasonal and year-round allergy symptoms (such as stuffy/runny nose, itchy eyes/nose/throat, sneezing). It may be used to treat symptoms (such as stuffy/runny nose) caused by other triggers (such as cigarette smoke, perfumes). It is also used to prevent the return of growths in the nose (nasal polyps) after removal by surgery. Beclomethasone belongs to a class of drugs known as corticosteroids. It works by reducing swelling (inflammation) in the nasal passages.

Regulatory & Marketing

Labeler Name
Aurolife Pharma Llc
Product Type
Human Prescription Drug
FDA Application #
ANDA214418
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
09-14-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 13107-230-54 identifies a specific commercial package of 1 canister in 1 carton / 120 aerosol, metered in 1 canister of Beclomethasone Dipropionate, a human prescription drug labeled by Aurolife Pharma Llc. This aerosol, metered is formulated for respiratory (inhalation) use and contains beclomethasone dipropionate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Aurolife Pharma Llc on September 14, 2026. The current certification is valid through December 31, 2027.

What are the primary indications for this medication?

Beclomethasone is used to prevent and treat seasonal and year-round allergy symptoms (such as stuffy/runny nose, itchy eyes/nose/throat, sneezing). It may be used to treat symptoms (such as stuffy/runny nose) caused by other triggers (such as cigarette smoke, perfumes). It is also used to prevent the return of growths in the nose (nasal polyps) after removal by surgery. Beclomethasone belongs to a class of drugs known as corticosteroids. It works by reducing swelling (inflammation) in the nasal passages.

How is this Aurolife Pharma Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 13107023054. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
13107-230-54
11-Digit CMS (5-4-2)
13107-0230-54

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.